Literature DB >> 31715232

Mitigation of isoquercitrin on β-lactoglobulin glycation: Insight into the mechanisms by mass spectrometry and interaction analysis.

Tian-Xin Ma1, Lu Zhang2, Liang Xu1, Yun-Hua Ye1, Tao Huang3, Qi-Ming Zhou4, Hai-Long Liu4.   

Abstract

Formation of advanced glycation end products (AGEs) on foods imposes threats to human health after intaking. This research firstly evaluated the inhibition of isoquercitrin on β-lactoglobulin (β-Lg) glycation, the mechanisms were elucidated by fluorescence spectroscopy, Orbitrap MSn and molecular docking. Fluorescence spectra indicated that isoquercitrin effectively alleviated the formation of AGEs, it could stabilize the conformation structure of glycated β-Lg (G-β-Lg), change the micro-environment in the vicinity of chromophores. SDS-PAGE analysis revealed the suppressed cross-linking of G-β-Lg induced by isoquercitrin. The number of glycation site detected on G-β-Lg was reduced from ten to eight after the addition of isoquercitrin, and the relative glycation degree of substitution of per site (RGDSP) of most glycation sites were also greatly decreased. As indicated by intermolecular interaction, isoquercitrin quenched the fluorescence of β-Lg via a static mechanism, and their combination is an endothermic processing mainly derived by hydrophobic interaction, hydrogen bonds, and van der Waals forces. Isoquercitrin interacted with β-Lg to form an equimolar complex, and one hydrogen bond was formed between isoquercitrin and Lys69 (4.96 Å). Above results proved that isoquercitrin can be a promising anti-glycation agent used in food system to prevent the formation of harmful glycation products.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-glycation; Intermolecular interaction; Isoquercitrin; Orbitrap MS(n); Structural changes

Mesh:

Substances:

Year:  2019        PMID: 31715232     DOI: 10.1016/j.ijbiomac.2019.11.080

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  2 in total

1.  Eriodictyol suppresses the malignant progression of colorectal cancer by downregulating tissue specific transplantation antigen P35B (TSTA3) expression to restrain fucosylation.

Authors:  Hua Huang; Yun He; Youran Li; Mingjia Gu; Minna Wu; Lijiang Ji
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

2.  Ultrasound-assisted assembly of β-lactoglobulin and chlorogenic acid for non covalent nanocomplex: fabrication, characterization and potential biological function.

Authors:  Jiayuan Liu; Gongshuai Song; Yawen Yuan; Like Zhou; Danli Wang; Tinglan Yuan; Ling Li; Guanghua He; Qingyu Yang; Gongnian Xiao; Jinyan Gong
Journal:  Ultrason Sonochem       Date:  2022-05-05       Impact factor: 9.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.